Gene · 54890
Papers4,144
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
681 to 700 of 4,144
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ALKBH5-mediated CHAC1 depletion promotes malignant progression and decreases cisplatin-induced oxidative stress in gastric cancer. | Cancer Cell Int | 2023 | 38007439 | PubTator, text mining | PubMed |
| M6A Demethylase Inhibits Osteogenesis of Dental Follicle Stem Cells via Regulating miR-7974/FKBP15 Pathway. | Int J Mol Sci | 2023 | 38003310 | PubTator, text mining | PubMed |
| METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway. | Cell Death Dis | 2023 | 38001065 | PubTator, text mining | PubMed |
| Identification of m6A Modification Regulated by Dysregulated circRNAs in Decidua of Recurrent Pregnancy Loss. | Curr Issues Mol Biol | 2023 | 37998728 | PubTator, text mining | PubMed |
| N6-methyladenosine-mediated overexpression of long noncoding RNA ADAMTS9-AS2 triggers neuroblastoma differentiation via regulating LIN28B/let-7/MYCN signaling. | JCI Insight | 2023 | 37991019 | PubTator, text mining | PubMed |
| Captive ERVWE1 triggers impairment of 5-HT neuronal plasticity in the first-episode schizophrenia by post-transcriptional activation of HTR1B in ALKBH5-m6A dependent epigenetic mechanisms. | Cell Biosci | 2023 | 37990254 | PubTator, text mining | PubMed |
| Identification and verification of m6A-related miRNAs correlated with prognosis and immune microenvironment in colorectal cancer. | Medicine (Baltimore) | 2023 | 37986290 | PubTator, text mining | PubMed |
| Discovery of Pyrazolo[1,5-a]pyrimidine Derivative as a Novel and Selective ALKBH5 Inhibitor for the Treatment of AML. | J Med Chem | 2023 | 37983486 | PubTator, text mining | PubMed |
| EGFR promotes ALKBH5 nuclear retention to attenuate N6-methyladenosine and protect against ferroptosis in glioblastoma. | Mol Cell | 2023 | 37979586 | PubTator, text mining | PubMed |
| Identification and validation of m6A RNA regulatory network in pulpitis. | BMC Oral Health | 2023 | 37978362 | PubTator, text mining | PubMed |
| PRMT3-Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma. | Adv Sci (Weinh) | 2023 | 37973560 | PubTator, text mining | PubMed |
| Downregulation of ALKBH5 rejuvenates aged human mesenchymal stem cells and enhances their therapeutic efficacy in myocardial infarction. | FASEB J | 2023 | 37966425 | PubTator, text mining | PubMed |
| The emerging role of m6A modification of non-coding RNA in gastrointestinal cancers: a comprehensive review. | Front Cell Dev Biol | 2023 | 37965577 | PubTator, text mining | PubMed |
| Editorial: Biomarkers, functional mechanisms, and therapeutic potentials in gastrointestinal cancers. | Front Oncol | 2023 | 37965472 | PubTator, text mining | PubMed |
| Progress in the study of FOXO3a interacting with microRNA to regulate tumourigenesis development. | Front Oncol | 2023 | 37965449 | PubTator, text mining | PubMed |
| Epigenetic control of plant senescence and cell death and its application in crop improvement. | Front Plant Sci | 2023 | 37965008 | PubTator, text mining | PubMed |
| Insights into the regulatory role of RNA methylation modifications in glioma. | J Transl Med | 2023 | 37964279 | PubTator, text mining | PubMed |
| Schnurri-3 drives tumor growth and invasion in cancer cells expressing interleukin-13 receptor alpha 2. | Cell Death Dis | 2023 | 37963919 | PubTator, text mining | PubMed |
| The N6-methyladenosine demethylase ALKBH5 regulates the hypoxic HBV transcriptome. | bioRxiv | 2023 | 37961409 | PubTator, text mining | PubMed |
| Role of UBE2C in Brain Cancer Invasion and Dissemination. | Int J Mol Sci | 2023 | 37958776 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54890/papers?page=35